CRDF

Conviction 0HealthcareScan · Mon, Aug 10, 2026

CRDF$1.03+3.84%

ResistanceSupportVol 14Insider buy

Vol MA14 927.29K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Cardiff Oncology, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.cardiffoncology.com ↗

Price1.03

Change+3.84%

Gap-1.20%

Rel volume0.71×

Avg volume1.72M

Avg $ vol1.53M

SMA 200.9064

SMA 501.19

SMA 2001.84

Price vs 50-13.41%

Price vs 200-43.90%

MA stackbearish

50/200 cross—

Supertrenddown · 1.04

RSI (14)51

MACD hist0.04

MACD crossbull · 6d

Stoch %K / %D83 / 92

ADX (14)29

+DI / −DI26 / 23

RSI divergence—

MACD divergence—

ATR %+7.87%

ADR %6.79%

52w high3.21

52w low0.8100

From 52w high-67.91%

Above 52w low+27.16%

New 52w highNo

SqueezeOff

Bollinger width48.74%

%B0.78

Donchian pos42.83%

Donchian high1.40

Donchian low0.7566

AVWAP (52w high)1.62

vs AVWAP high-36.26%

AVWAP (52w low)0.9058

vs AVWAP low+13.71%

OBV trendDown

Chaikin MF (20)-0.00

Today vs 20d0.71×

Avg vol (14d)927.29K

Avg vol (20d)1.72M

Avg $ vol (20d)1.53M

Market cap70.42M

RS 3m (vs SPY)-43.70%

RS 6m (vs SPY)-47.09%

RS line new highNo

Trend template0/8

Technical rank13.2

1 week+10.28%

1 month-22.56%

3 months-37.20%

6 months-35.63%

1 year-57.26%

YTD-61.28%

P/E-1.54

P/B2.03

P/S118.75

P/FCF-1.85

EPS-0.6900

Div yield—

ROE-132.10%

ROA-93.25%

Debt/Eq—

Current3.27

EV/EBITDA-1.27

Gross margin—

Net margin—

Rev growth-13.18%

EPS growth-0.92%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value61.88M

Revenue41K

Net income-12.35M

Gross profit—

Free cash flow-37.97M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out68.37M

Employees31

ListedThu, May 22, 1997

Free float64.31M

Float %94.1%

Short interest12.09M

Days to cover6.2d

Short volume63.5%

Squeeze score78 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank13.2 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance1.43

Support0.7783

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CRDF

All disclosures →

No recent disclosed trades by Congress in CRDF. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CRDF · 9 buys

Insider	Side	Shares	Value	Traded	Filed
Mohindru Mani Chief Executive Officer · Common Stock Purchase Warrant · 2026-07-14	Buy	34.36K	—	2026-07-14	2026-07-16
Mohindru Mani Chief Executive Officer · Common Stock · 2026-07-14	Buy	34.36K	$50K	2026-07-14	2026-07-16
PACE GARY W Director · Common Stock · 2026-07-14	Buy	687.28K	$1000K	2026-07-14	2026-07-16
PACE GARY W Director · Common Stock Purchase Warrant · 2026-07-14	Buy	687.28K	—	2026-07-14	2026-07-16
Mohindru Mani Chief Executive Officer · Common Stock · 2026-06-18	Buy	24.7K	$30K	2026-06-18	2026-06-22
PACE GARY W Director · Common Stock · 2026-06-18	Buy	30K	$37K	2026-06-18	2026-06-22
Aggarwal Ajay Chief Operating Officer · Stock Options · 2026-04-27	Grant	400K	$0	2026-04-27	2026-04-28
Smeal Tod Chief Scientific Officer · Stock Options · 2026-04-14	Grant	300K	$0	2026-04-14	2026-04-16
Muntner Joshua B Chief Financial Officer · Common Stock · 2026-04-06	Other	—	—	2026-04-06	2026-04-16
Muntner Joshua B Chief Financial Officer · Stock Options · 2026-04-06	Grant	486.65K	$0	2026-04-06	2026-04-16

SEC filings

EDGAR filings in CRDF · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.